Literature DB >> 25699981

The Current Status of Tissue-Engineered Vascular Grafts.

Vita N Jaspan1, George L Hines.   

Abstract

Tissue-engineered vascular grafts (TEVGs) are currently being developed to overcome the limitations and complications associated with traditional synthetic grafts. This article aims to review the current status of research into the production and use of tissue-engineered grafts. TEVGs have a number of theoretical advantages over synthetic grafts. The results of animal and human studies have been promising, but more work must be done before TEVGs can replace traditional grafts.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25699981     DOI: 10.1097/CRD.0000000000000060

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  4 in total

1.  Knowledge Domain and Hotspots Predict Concerning Electroactive Biomaterials Applied in Tissue Engineering: A Bibliometric and Visualized Analysis From 2011 to 2021.

Authors:  Wentao Xiong; Sheng Wang; Ziheng Wei; Yibo Cai; Bo Li; Feng Lin; Demeng Xia
Journal:  Front Bioeng Biotechnol       Date:  2022-05-23

2.  A Brief Report on an Implantation of Small-Caliber Biodegradable Vascular Grafts in a Carotid Artery of the Sheep.

Authors:  Larisa V Antonova; Andrey V Mironov; Arseniy E Yuzhalin; Evgeniya O Krivkina; Amin R Shabaev; Maria A Rezvova; Vadim O Tkachenko; Mariam Yu Khanova; Tatiana Yu Sergeeva; Sergei S Krutitskiy; Leonid S Barbarash
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-21

3.  Prosthetic graft infection after vascular trauma.

Authors:  Kathryn Tchorz; Grace Rozycki; David V Feliciano
Journal:  Trauma Surg Acute Care Open       Date:  2020-11-03

4.  Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivo.

Authors:  Liang Zhao; Xiafei Li; Lei Yang; Lulu Sun; Songfeng Mu; Haibin Zong; Qiong Li; Fengyao Wang; Shuang Song; Chengqiang Yang; Changhong Zhao; Hongli Chen; Rui Zhang; Shicheng Wang; Yuzhen Dong; Qiqing Zhang
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-08-25       Impact factor: 7.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.